Skip to main content
Login
institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

Published • loading... • Updated

Drugmakers Score Policy Win in Fight Against 340B

UNITED STATES, AUG 4 – The pilot program will test replacing upfront discounts with rebates on 10 drugs to assess impacts on oversight and program integrity, with nearly 60% of hospitals involved in 340B.

Summary by biopharmadive.com
A new pilot program from HHS will test alterations to the contentious 340B pricing program by swapping traditional upfront drug discounts for rebates.

2 Articles

PharmaVOICEPharmaVOICE
Center

Drugmakers score policy win in a prolonged fight against 340B

A new pilot program from HHS would alter the contentious 340B pricing program by swapping traditional upfront drug discounts for rebates.

Read Full Article
biopharmadive.combiopharmadive.com
Center

Drugmakers score policy win in fight against 340B

A new pilot program from HHS will test alterations to the contentious 340B pricing program by swapping traditional upfront drug discounts for rebates.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

biopharmadive.com broke the news in on Monday, August 4, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

Pharma icon

Pharma

Drug Prices icon

Drug Prices

News
For You
SearchBlindspotLocal